Tumourigenic multidrug-resistant HT1080 cells do not overexpress receptors for epidermal growth factor.
作者信息
Slovak M L, Mirski S E, Cole S P, Gerlach J H, Yohem K H, Trent J M
机构信息
Department of Cytogenetics, City of Hope National Medical Center, Duarte, California 91010.
出版信息
Br J Cancer. 1991 Aug;64(2):296-8. doi: 10.1038/bjc.1991.295.
Abstract
摘要
相似文献
1
Tumourigenic multidrug-resistant HT1080 cells do not overexpress receptors for epidermal growth factor.
Br J Cancer. 1991 Aug;64(2):296-8. doi: 10.1038/bjc.1991.295.
2
The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype.
Cancer Immunol Immunother. 1993 Jun;36(6):381-6. doi: 10.1007/BF01742254.
3
Amplification and overexpression of the P-glycoprotein genes and differential amplification of three other genes in SEWA murine multidrug-resistant cells.
Hereditas. 1988;108(2):251-8. doi: 10.1111/j.1601-5223.1988.tb00310.x.
4
Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line.
Br J Cancer. 1990 Jun;61(6):851-5. doi: 10.1038/bjc.1990.190.
5
Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms.
Anticancer Res. 1991 Jan-Feb;11(1):423-8.
6
Crosstalk between epidermal growth factor receptor and P-glycoprotein in actinomycin D-resistant Chinese hamster lung cells.
Biochem Pharmacol. 1993 Nov 17;46(10):1841-8. doi: 10.1016/0006-2952(93)90591-j.
7
Multidrug resistance (MDR 1) in leukemia: is it time to test?
Blood. 1992 Jan 15;79(2):295-8.
8
Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.
Br J Cancer. 1989 Jan;59(1):42-6. doi: 10.1038/bjc.1989.9.
9
HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
J Natl Cancer Inst. 1990 Oct 3;82(19):1553-61. doi: 10.1093/jnci/82.19.1553.
10
Mechanism of multidrug resistance.
Biochim Biophys Acta. 1988 Aug 3;948(1):87-128. doi: 10.1016/0304-419x(88)90006-6.
引用本文的文献
1
Human cell lines as models for multidrug resistance in solid tumours.
Cytotechnology. 1993;12(1-3):231-56. doi: 10.1007/BF00744666.
本文引用的文献
1
Expression of drug sensitivity and tumorigenicity in intraspecies hybrids between 9-hydroxyellipticine-sensitive and -resistant cells.
Cancer Res. 1984 Oct;44(10):4587-93.
2
Properties of the receptor for epidermal growth factor.
Cell. 1984 Jun;37(2):357-8. doi: 10.1016/0092-8674(84)90365-9.
3
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.
Nature. 1984;307(5951):521-7. doi: 10.1038/307521a0.
4
Adriamycin causes up regulation of epidermal growth factor receptors in actively growing cells.
Exp Cell Res. 1983 Oct;148(1):155-61. doi: 10.1016/0014-4827(83)90195-7.
5
Identity of human epidermal growth factor (EGF) receptor with glycoprotein SA-7: evidence for differential phosphorylation of the two components of the EGF receptor from A431 cells.
Proc Natl Acad Sci U S A. 1982 Aug;79(16):5026-30. doi: 10.1073/pnas.79.16.5026.
6
Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.
Science. 1984 Apr 27;224(4647):417-9. doi: 10.1126/science.6200934.
7
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5201-5. doi: 10.1073/pnas.77.9.5201.
8
Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations.
Cancer Res. 1987 Dec 15;47(24 Pt 1):6646-52.
9
Location of genes involved in invasion and metastasis on human chromosome 7.
Cancer Res. 1987 Dec 15;47(24 Pt 1):6666-70.
10
Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.
Cell. 1987 Oct 23;51(2):199-209. doi: 10.1016/0092-8674(87)90147-4.
Zotero 插件